CLINICAL_TRIALS
trial_result
· 2016-12-29
Clinical Trial Update: Glycine vs Placebo for the Schizophrenia Prodrome [Phase 2, Phase 3]
Summary
Phase 2/3 clinical trial comparing glycine to placebo in individuals at risk for schizophrenia shows completed status with results posted in 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Yale University | Conditions: Schizophrenia Prodrome | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2016-12-29